Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
67.9M
-
Shares change
-
-1.38M
-
Total reported value, excl. options
-
$1.57B
-
Value change
-
-$32.5M
-
Put/Call ratio
-
5.81
-
Number of buys
-
66
-
Number of sells
-
-55
-
Price
-
$23.12
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q3 2023
160 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2023.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.9M shares
of 75.6M outstanding shares and own 89.85% of the company stock.
Largest 10 shareholders include FMR LLC (9.39M shares), VANGUARD GROUP INC (4.92M shares), BlackRock Inc. (4.43M shares), ORBIMED ADVISORS LLC (3.97M shares), Deep Track Capital, LP (3.55M shares), EcoR1 Capital, LLC (3.46M shares), Boxer Capital, LLC (3.42M shares), Bain Capital Life Sciences Investors, LLC (3.08M shares), BAKER BROS. ADVISORS LP (3M shares), and STATE STREET CORP (2.57M shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.